MLYS
NASDAQ · Biotechnology
Mineralys Therapeutics Inc
$15.55
-2.63 (-14.47%)
Performance
1D
-8.53%
1W
-26.79%
1M
-29.16%
3M
-43.14%
6M
-47.70%
1Y
-60.78%
YTD
-56.45%
Open$18.27
Previous Close$18.18
Day High$18.29
Day Low$15.42
52W High$47.65
52W Low$20.12
Volume—
Avg Volume1.36M
Market Cap1.61B
P/E Ratio—
EPS$-4.24
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$24.20
Below
SMA 200
$26.75
Below
RSI (14)
31.4
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
16 analysts
Price Target
+499.3% upside
Current
$15.55
$15.55
Target
$93.19
$93.19
$50.31
$93.19 avg
$121.15
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 422.84M | 383.53M | 332.94M |
| Net Income | 48.98M | 43.51M | 33.06M |
| Profit Margin | 11.6% | 11.3% | 9.9% |
| EBITDA | 63.20M | 67.45M | 57.44M |
| Free Cash Flow | 26.85M | 26.46M | 31.26M |
| Rev Growth | +5.2% | +16.0% | +2.3% |
| Debt/Equity | 0.29 | 0.28 | 0.28 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $294.83 | +3.09% | 81.4 | 513.86B |
| AMGN | Amgen Inc | $478.48 | +3.73% | 28.5 | 249.09B |
| GILD | Gilead Sciences Inc | $174.48 | +4.19% | — | 212.04B |
| VRTX | Vertex Pharmaceuticals Inc | $549.04 | +3.44% | 30.6 | 134.77B |
| REGN | Regeneron Pharmaceuticals | $930.67 | -4.39% | 19.5 | 84.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $161.08 | +0.74% | 28.8 | 23.28B |